Pandemic spotlights the rise of mobile research nursing

The impact of the COVID-19 pandemic on clinical trials has been well chronicled in recent months, with new and ongoing studies targeting a number of diseases, particularly chronic conditions, being hit hard by reductions in patient participation.  This has shifted fundamental approaches […]

Read More

Adverse event reporting: NLP’s new niche?

Getting critical treatments approved and delivered to market is no easy feat. Currently, only 15% of drugs successfully make it from clinical trials to U.S. FDA approval—with nearly 75% of failures attributed to safety and efficacy concerns. Once drugs do […]

Read More